Lv55
1560 积分 2022-09-02 加入
Primary central nervous system marginal zone lymphoma
2天前
已完结
Polatuzumab vedotin, venetoclax, and an anti‐CD20 monoclonal antibody in relapsed/refractory B‐cell non‐Hodgkin lymphoma
2天前
已完结
A phase 2 study of venetoclax plus R-CHOP as first-line treatment for patients with diffuse large B-cell lymphoma
2天前
已关闭
Pediatric Primary Cutaneous Marginal Zone Lymphoma Treated With Doxycycline
6天前
已关闭
Marginal-Zone Lymphomas
10天前
已完结
Improvement in Sjögren's syndrome following therapy with rituximab for marginal zone lymphoma
10天前
已完结
Prognostic markers of lymphoma development in primary Sjögren syndrome
10天前
已完结
Safety and efficacy of ibrutinib in combination with rituximab and lenalidomide in previously untreated follicular and marginal zone lymphoma: An open label, phase 2 study
17天前
已完结
Successful treatment of relapsed idiopathic multicentric Castleman disease–idiopathic plasmacytic lymphadenopathy with orelabrutinib monotherapy: A case report
1个月前
已完结
Efficacy and safety of orelabrutinib in relapsed/refractory idiopathic multicentric Castleman disease: A single‐centre, retrospective study
1个月前
已完结
皖公网安备34019202002308
